Profile data is unavailable for this security.
About the company
Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.
- Revenue in CAD (TTM)20.93m
- Net income in CAD-2.63m
- Incorporated2000
- Employees25.00
- LocationMedicure Inc1250 Waverley StreetWINNIPEG R3T 6C6CanadaCAN
- Phone+1 (204) 487-7412
- Fax+1 (204) 487-7412
- Websitehttps://www.medicure.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TFF Pharmaceuticals Inc | 1.20m | -19.39m | 6.52m | 19.00 | -- | 1.04 | -- | 5.42 | -7.95 | -7.95 | 0.4659 | 1.81 | 0.1043 | -- | 3.51 | 63,293.68 | -168.10 | -79.57 | -212.66 | -83.41 | -- | -- | -1,612.04 | -8,687.66 | -- | -- | 0.00 | -- | 48.01 | -- | 33.13 | -- | -- | -- |
ABVC Biopharma Inc | 136.40k | -11.37m | 6.67m | 16.00 | -- | 0.7808 | -- | 48.93 | -1.78 | -1.78 | 0.0172 | 0.6882 | 0.0114 | -- | 0.4213 | 8,525.00 | -99.79 | -103.38 | -197.79 | -231.54 | -24.11 | 76.25 | -8,762.13 | -2,019.89 | -- | -2.50 | 0.1873 | -- | -84.28 | 85.39 | 35.97 | -- | -- | -- |
Cannabis Bioscience Internatnl Hlgs Inc | 56.94m | 6.94m | 6.78m | 389.00 | 0.0012 | 0.0001 | 0.735 | 0.1191 | 0.5328 | 0.5328 | 4.29 | 4.92 | 0.5917 | 62.81 | 1.45 | 146,384.30 | 7.83 | -- | 11.73 | -- | 31.96 | -- | 13.24 | -- | 0.6856 | 50.75 | 0.0631 | -- | 12.79 | -- | 177.84 | -- | -- | -- |
Viaderma Inc | 17.80m | 2.31m | 6.79m | 75.00 | 0.0003 | 0.00002 | 1.25 | 0.3812 | 16.84 | 16.84 | 129.62 | 255.59 | 0.4126 | 24.69 | 1.21 | 237,331.30 | 5.36 | -- | 6.53 | -- | 28.90 | -- | 12.99 | -- | 2.07 | 5.66 | 0.1718 | -- | -29.15 | -- | -40.70 | -- | -- | -- |
Medicure Inc | 15.27m | -1.92m | 7.00m | 25.00 | -- | 0.4979 | -- | 0.4587 | -0.1845 | -0.1845 | 1.42 | 1.37 | 0.7288 | 2.28 | 4.38 | 610,707.50 | -9.16 | -13.42 | -12.73 | -18.28 | 61.41 | 61.87 | -12.56 | -27.38 | 1.42 | -- | 0.0202 | -- | -5.94 | -5.71 | -167.55 | -- | -28.82 | -- |
Organovo Holdings Inc | 73.00k | -13.99m | 7.04m | 12.00 | -- | 0.9879 | -- | 96.38 | -1.39 | -1.39 | 0.0069 | 0.4635 | 0.006 | -- | 0.7411 | 3,650.00 | -115.47 | -54.25 | -136.97 | -58.42 | 50.68 | -- | -19,160.27 | -1,890.16 | 3.38 | -- | 0.00 | -- | -70.54 | -48.78 | 15.00 | -- | -11.87 | -- |
Cyclerion Therapeutics Inc | 0.00 | -10.47m | 7.05m | 1.00 | -- | 0.7448 | -- | -- | -4.26 | 1.27 | 0.00 | 3.49 | 0.00 | -- | -- | 0.00 | -103.82 | -72.70 | -150.23 | -86.96 | -- | -- | -- | -2,565.62 | -- | -- | 0.00 | -- | -100.00 | -- | 30.98 | -- | -- | -- |
Alzamend Neuro Inc | 0.00 | -7.39m | 7.16m | 4.00 | -- | -- | -- | -- | -10.69 | -10.69 | 0.00 | -1.41 | 0.00 | -- | -- | 0.00 | -344.10 | -177.86 | -- | -257.81 | -- | -- | -- | -- | -- | -363.62 | -- | -- | -- | -- | 33.14 | -- | -- | -- |
Portage Biotech Inc | 0.00 | -71.08m | 7.24m | 7.00 | -- | 2.88 | -- | -- | -68.81 | -68.81 | 0.00 | 2.39 | 0.00 | -- | -- | 0.00 | -137.29 | -30.53 | -143.21 | -40.02 | -- | -- | -- | -- | -- | -- | 0.02 | -- | -- | -- | 27.98 | -- | -- | -- |
Mosaic Immunoengineering Inc | 0.00 | -1.21m | 7.24m | 3.00 | -- | -- | -- | -- | -0.1674 | -0.1674 | 0.00 | -0.8904 | 0.00 | -- | -- | 0.00 | -634.64 | -- | -- | -- | -- | -- | -- | -- | -- | -14.05 | -- | -- | -- | -- | 57.65 | -- | -- | -- |
Kineta Inc | 0.00 | -20.88m | 7.25m | 11.00 | -- | -- | -- | -- | -1.79 | -1.79 | 0.00 | -0.6638 | 0.00 | -- | -- | 0.00 | -220.35 | -66.16 | -- | -86.61 | -- | -- | -- | -854.74 | -- | -- | -- | -- | 178.65 | 13.89 | 77.76 | -- | -- | -- |
Moleculin Biotech Inc | 0.00 | -25.17m | 7.25m | 18.00 | -- | 0.3688 | -- | -- | -11.62 | -11.62 | 0.00 | 6.91 | 0.00 | -- | -- | 0.00 | -69.24 | -46.84 | -83.35 | -51.49 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -2.56 | -- | -21.54 | -- |
Virax Biolabs Group Ltd | 156.42k | -6.73m | 7.29m | 17.00 | -- | 0.8585 | -- | 46.62 | -3.35 | -3.35 | 0.078 | 2.09 | 0.0205 | 3.51 | -- | 9,201.18 | -88.11 | -- | -91.88 | -- | 32.34 | -- | -4,308.35 | -- | 25.58 | -227.16 | 0.0418 | -- | 1,727.34 | -- | -23.38 | -- | -- | -- |
Forte Biosciences Inc | 0.00 | -35.76m | 7.30m | 11.00 | -- | 0.4297 | -- | -- | -22.03 | -22.03 | 0.00 | 11.64 | 0.00 | -- | -- | 0.00 | -124.89 | -72.06 | -170.91 | -82.27 | -- | -- | -- | -491,850.00 | -- | -- | 0.00 | -- | -- | -- | -126.79 | -- | -46.29 | -- |
BioNexus Gene Lab Corp | 9.18m | -2.21m | 7.37m | 30.00 | -- | 0.7589 | -- | 0.8022 | -0.1108 | -0.1108 | 0.5807 | 0.5403 | 0.9647 | 7.19 | 5.77 | -- | -23.17 | -3.83 | -27.98 | -5.02 | 13.88 | 14.55 | -24.02 | -3.04 | 4.87 | -118.92 | 0.00 | -- | -10.60 | 115.07 | -638.56 | -- | 30.40 | -- |
Holder | Shares | % Held |
---|---|---|
MM Asset Management, Inc.as of 31 Dec 2023 | 2.41m | 23.10% |